Silexion Therapeutics Financial Overview
Silexion Therapeutics's market cap is currently $7.50M. The company's EPS TTM is $-2.88; its P/E ratio is -0.10; Silexion Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-1.12. See an overview of income statement, balance sheet, and cash flow financials.
